ApprovedCountry-specific / investigational elsewhere

Mazdutide

Brand examples:IBI362LY3305677

Class: Country-specific / investigational elsewhere
Route: SC injection
Frequency: Once weekly in trials/product context
GLP-1 relevance: Yes

How it works

Dual glucagon/GLP-1 receptor agonist / oxyntomodulin analog

Approved & studied uses

Weight management; type 2 diabetes pipeline/China market

Regulatory status

Approved in China; investigational elsewhere

Safety notes

Approval is country-specific; this compound is not approved globally.

Sources

Mazdutide NEJM/PubMed
China NMPA regulatory filing (press release)

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.